Aaron Kesselheim in the NEJM
Aaron Kesselheim (2009 Awardee) co-authored "New FDA Breakthrough-Drug Category — Implications for Patients" published in the New England Journal of Medicine (2014; 370:1252-1258).
Aaron Kesselheim (2009 Awardee) co-authored "New FDA Breakthrough-Drug Category — Implications for Patients" published in the New England Journal of Medicine (2014; 370:1252-1258).
Howard Markel (2007 Awardee) co-authors "Donabedian’s Lasting Framework for Health Care Quality." in The New England Journal of Medicine, 375, pp. 205-207, July 21, 2016.
Peter Ubel (2007 Awardee) co-authored "Promoting Population Health through Financial Stewardship" in the New England Journal of Medicine (2014; 370:1280-1281).
David Blumenthal (2002 Awardee) co-authors "Caring for High-Need, High-Cost Patients — An Urgent Priority" in The New England Journal of Medicine, 375, pp. 909-911, online July 27, 2016.
Aaron Kesselheim (2009 Awardee) co-authored "Using a Drug-Safety Tool to Prevent Competition" in the New England Journal of Medicine (2014; 370:1476-1478).
Aaron Kesselheim (2011 Awardee) co-authored an article called, "Regulating Off-Label Promotion — A Critical Test" in the New England Journal of Medicine, November 2, 2016.
Lisa Iezzoni (1996 Awardee) co-authored "The Axes of Access — Improving Care for Patients with Disabilities" published in The New England Journal of Medicine (2014; 370:1847-1851).
Ronald Bayer (2001 Awardee) co-authored the news article, "The Paradox of Authority — Transformation of the USPSTF under the Affordable Care Act" in the New England Journal of Medicine, November 3, 2016.
David Rothman (2003 Awardee) authored "Where We Die" in the New England Journal of Medicine (2014; 370:2457-2460).
Michael Sparer (2002 Awardee) authors "Maintaining Insurance Access under Trump — A Strategy" in New England Journal of Medicine, 375, pp. 2509-2511, November 16, 2016.